Category Archives: Policy News

Salt Lake City, UT, Thursday, October 18, 2018 –Mountain Pacific Venture Fund announced today its investment in Decoy Biosystems, a San Diego, California-based cancer immunotherapy company that was recently accepted into the Johnson & Johnson Innovation, JLABS (JLABS) life science incubator. The investment was part of a $6.0 million seed round syndicated with TY BIO […]

SALT LAKE CITY, UT (September 28, 2018) – BioUtah today announced that the board of directors has selected Kelvyn H. Cullimore Jr. as its president and CEO. Cullimore will succeed Kelly Slone, who has served in that capacity for the past three years.   Cullimore comes to BioUtah with deep experience in both industry and […]

Dr. Shuren will take the stage as the luncheon keynote at the 2018 BioUtah Utah Life Sciences Summit, speaking to the state’s premier gathering of industry leaders, innovators, government officials, educators, and investors September 14, 2018 10:00 AM Eastern Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–BioUtah, Utah’s only trade association dedicated solely to the life sciences community, […]

Registration opens today for the 2018 BioUtah ULSS, offering early bird discounts. Preliminary speaker line-up includes notable business leaders, policy makers and members of the investor community Salt Lake City, UT – September 5, 2018 – BioUtah, Utah’s one and only association dedicated to the life sciences community, today announced that registration is open for […]

On November 1, BioUtah will be holding its 9th annual Utah Life Sciences Summit (ULSS). This is the premier conference for companies on the cutting edge of medical innovation, and provides a unique opportunity to connect with national leaders in the life sciences industry. Please join us for keynote speakers, panels, and networking opportunites that […]

BioUtah is pleased to share with you the newly released study by the Kem C. Gardner Policy Institute on the impact of Utah’s life sciences industry on the state’s economy. The study, the “Economic Impacts of Utah’s Life Sciences Industry” can be viewed in full here. The Gardner Policy Institute announced the study’s findings this […]

Salt Lake City, August 1, 2018: Mountain Pacific Venture Partners, a Salt Lake City-based venture capital firm, has closed the first institutional investment into its debut fund, which invests in and supports innovative life science and biotech companies. The investment into Mountain Pacific Venture Fund was made by TY BIO Investment, Inc., a wholly-owned subsidiary […]

FOR IMMEDIATE RELEASE July 25, 2018 BioUtah Statement on U.S. House of Representatives Passage of  Legislation to Permanently Repeal the Medical Device Tax Salt Lake City – BioUtah issued the following statement from President and CEO, Kelly Slone, regarding passage of the Protect Medical Innovation Act of 2017 (H.R. 184) in the U.S. House of […]

Please join us and Global Genes on Saturday, June 30th for RARE on the Road Rare Disease Leadership Tour in Salt Lake City, Utah. This conference will educate rare disease patients, caregivers and other advocates through collaboration in an interactive and engaging environment.

Biomerics LLC, a medical device contract manufacturer headquartered in Salt Lake City, UT is pleased to announce the acquisition of FutureMatrix Interventional, Inc. FMI, located in Athens, TX specializes in the design and manufacture of interventional catheters for the cardiovascular and urology markets.

Joins us for a timely update from Brian Carey, Partner, Foley Hoag, on reimbursement trends for precision medicine and Kim Linthicum, Vice President of Government Affairs, Myriad, on proposed legislation that would create a new regulatory pathway for diagnostics.

The MedTech Conference will take place on September 24th – 26th 2018 at the Pennsylvania Convention Center in Philadelphia.